Aza-SAHA-GBM
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aza-SAHA-GBM, covering 2020-01-27 to 2020-01-27. Get the full timeline:
Most recent: Clinical Trial Update: Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma [Phase 1, Phase 2]